CCL11 and breast carcinoma: The administration of a DPP4 inhibitor in mice with subcutaneous EMT6 breast cancer cell implantation induced intratumoral accumulation of CCL11, resulting in eosinophilic chemotaxis and reduced tumor growth [35].